Actionable news
0
All posts from Actionable news
Actionable news in PVCT: PROVECTUS BIOPHARMACEUTICALS Inc,

PROVECTUS BIOPHARMACEUTICALS: Peter R. Culpepper, Cfo, Coo

The following excerpt is from the company's SEC filing.

Phone: 866-594-5999 #30

Porter, LeVay & Rose, Inc.

Marlon Nurse, DM, SVP Investor Relations

Phone: 212-564-4700

Todd Aydelotte - Media Relations

Phone: 646-428-0644

FOR IMMEDIATE RELEASE

PROVECTUS BIOPHARMACEUTICALS WILL HOLD ITS 2015 THIRD QUARTER

BUSINESS UPDATE CONFERENCE CALL ON THURSDAY, NOVEMBER 5, 2015,

AT 5 PM EASTERN STANDARD TIME

Call to be Webcast, Available for Digital Replay

KNOXVILLE, TN

, October 20, 2015 Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, http://www.pvct.com), a clinical-stage oncology and d ermatology biopharmaceutical company (Provectus), announced today that it will hold its 2015 third quarter business update conference call at 5 pm Eastern Standard Time on Thursday, November 5, 2015.

Management will provide a business update on PV-10 and PH-10 to the investment community and answer questions from investors.

Those who wish to participate in the conference call may telephone 877-407-4019 from the U.S. International callers may telephone 201-689-8337 approximately fifteen minutes before the call. A webcast will also be available at www.pvct.com.

A digital replay will be available by telephone approximately two hours after the completion of the call until January 31, 2015 and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, and using the Conference ID #13623105.

About Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals, Inc....


More